Benztropine or its salts |
including but not limited to benzatropine
|
I |
DEC / 13 |
Benzydamine or its salts |
|
I |
DEC / 13 |
Benzyl benzoate |
|
II |
SEP / 98 |
Bepotastine or its salts or derivatives |
|
I |
NOV / 16 |
Beractant |
|
I |
DEC / 13 |
Besifloxacin or its salts |
|
I |
DEC / 13 |
Betahistine or its salts |
|
I |
DEC / 13 |
Betaine or its salts |
for human use, when sold or recommended for the treatment of homocystinuria
|
I |
DEC / 13 |
Betaine or its salts. |
for veterinary use
|
I |
DEC / 13 |
Betaxolol or its salts |
|
I |
DEC / 13 |
Bethanechol chloride |
|
I |
DEC / 13 |
Bethanidine or its salts |
|
I |
DEC / 13 |
Bevacizumab |
|
I |
DEC / 13 |
Bezafibrate or its salts or derivatives |
|
I |
DEC / 13 |
Bicalutamide |
|
I |
DEC / 13 |
Bictegravir or its salts |
|
I |
AUG / 18 |
Bilastine or its salts or derivatives |
|
I |
AUG / 16 |
Biperiden or its salts |
|
I |
DEC / 13 |
Bisacodyl |
when sold in concentrations of 5mg or less per oral dosage unit or 10mg or less per rectal dosage unit/suppository, in package sizes containing no more than 50mg of bisacodyl |
U |
JAN / 14 |
Bisacodyl and its salts |
(except when sold in concentrations of 5mg or less per oral dosage unit or 10mg or less per rectal dosage unit/suppository in package sizes containing no more than 50mg of bisacodyl)
|
III |
JAN / 14 |
Bishydroxycoumarin or its salts or derivatives |
|
I |
DEC / 13 |
Bisoprolol or its salts |
|
I |
DEC / 13 |
Bitolterol or its salts |
|
I |
DEC / 13 |
Bivalirudin |
|
I |
DEC / 13 |
Bleomycin |
|
I |
DEC / 13 |
Blinatumomab |
|
I |
AUG / 16 |
Boceprevir or its derivatives |
|
I |
DEC / 13 |
Boric acid and its salts |
in preparations for systemic use, or ophthalmic preparations in concentrations over 2%[Note: does not apply to contact lens solutions intended to be rinsed off prior to insertion in the eye] |
II |
DEC / 98 |
Bortezomib |
|
I |
DEC / 13 |
Bosentan or its salts or derivatives |
|
I |
DEC / 13 |
Bosutinib or its salts |
including but not limited to Bosutinib methanoate
|
I |
AUG / 14 |
Botulinum toxin |
including but not limited to onabotulinumtoxin A, incobotulinumtoxin A, abobotulinumtoxin A, rimabotulinumtoxin B, prabotulinumtoxin A
|
I |
DEC / 13 |
Brentuximab vedotin |
|
I |
DEC / 13 |
Bretylium tosylate |
|
I |
DEC / 13 |
Brexpiprazole or its salts |
|
I |
APR / 17 |
Brigatinib or its salts |
|
I |
AUG / 18 |
Brimonidine or its salts |
|
I |
DEC / 13 |
Brivaracetam or its derivatives |
|
I |
AUG / 16 |
Brodalumab |
|
I |
MAY / 18 |
Brolucizumab |
|
I |
JUL / 20 |
Bromal |
|
I |
DEC / 13 |
Bromal hydrate |
|
I |
DEC / 13 |
Brometone |
|
I |
DEC / 13 |
Bromfenac or its salts |
|
I |
MAY / 15 |
Bromisoval |
|
I |
DEC / 13 |
Bromocriptine or its salts |
|
I |
DEC / 13 |
Bromoform |
|
I |
DEC / 13 |
Brompheniramine and its salts |
as a single entity for the treatment of allergies |
III |
JAN / 03 |
Brompheniramine and its salts. |
in combination products for the relief of cough and cold symptoms |
U |
JAN / 03 |
Buclizine |
|
II |
SEP / 98 |
Bufexamac |
|
II |
SEP / 98 |
Bumetanide or its salts or derivatives |
|
I |
DEC / 13 |
Bupivacaine and its salts |
for topical use on mucous membranes except lozenges |
III |
SEP / 98 |
Bupivacaine and its salts |
for parenteral or ophthalmic use |
II |
SEP / 98 |
Bupropion or its salts |
|
I |
DEC / 13 |
Burosumab |
|
I |
DEC / 18 |
Buserelin or its salts |
|
I |
DEC / 13 |
Buspirone or its salts |
|
I |
DEC / 13 |
Busulfan |
|
I |
DEC / 13 |
Butacaine and its salts |
for ophthalmic or parenteral use |
II |
SEP / 98 |
Butaperazine or its salts |
|
I |
DEC / 13 |
Butenafine |
1% cream |
U |
SEP / 99 |
Butoconazole or its salts |
|
I |
DEC / 13 |
Butorphanol and its salts C |
|
I |
JUN / 02 |
Butyl chloral hydrate |
|
I |
DEC / 13 |
Cabergoline or its salts |
|
I |
DEC / 13 |
Cabotegravir or its salts |
|
I |
JUL / 20 |
Cabozantinib or its salts |
|
I |
NOV / 18 |
Calcifediol |
|
I |
JUL / 18 |
Calcipotriol |
|
I |
DEC / 13 |
Calcitonin |
|
I |
DEC / 13 |
Calcitriol |
|
I |
DEC / 13 |
Calcium bromide |
|
I |
DEC / 13 |
Calcium bromolactobionate |
|
I |
DEC / 13 |
Calcium carbimide |
|
I |
DEC / 13 |
Calcium chloride in injectable form for parenteral nutrition |
|
I |
JAN / 03 |
Calcium disodium edetate |
|
II |
SEP / 98 |
Calcium gluconate in injectable form for parenteral nutrition |
|
I |
JAN / 03 |
Calcium polycarbophil |
|
III |
SEP / 98 |
Calcium salts when sold for the treatment of hyperphosphatemia |
|
I |
DEC / 13 |
Camphor |
in oleaginous vehicles and in liquid forms in concentrations greater than 11% |
II |
OCT / 98 |
Canagliflozin |
|
I |
JUL / 14 |
Canakinumab |
|
I |
DEC / 13 |
Candesartan or its salts or derivatives |
including but not limited to candesartan cilexetil
|
I |
DEC / 13 |
Candicidin or its salts or derivatives |
|
I |
DEC / 13 |
Cantharides, their preparations and derivatives |
|
II |
SEP / 98 |
Caplacizumab |
|
I |
JUL / 20 |
Capreomycin or its salts ir deriviatives |
|
I |
DEC / 13 |
Captodiamine or its salts |
|
I |
DEC / 13 |
Captopril or its salts |
|
I |
DEC / 13 |
Carbachol |
|
I |
DEC / 13 |
Carbamazepine |
|
I |
DEC / 13 |
Carbapenem salts or derivatives |
Including but not limited to: Doripenem, ertapenem, imipenem, meropenem
|
I |
DEC / 18 |
Carbenoxolone or its salts |
|
I |
DEC / 13 |
Carbetocin or its salts |
|
I |
DEC / 13 |
Carbidopa or its salts |
|
I |
DEC / 13 |
Carbimazole |
|
I |
DEC / 13 |
Carbinoxamine or its salts |
|
III |
SEP / 98 |
Carbocisteine |
|
I |
DEC / 13 |
Carbomycin or its salts or derivatives |
|
I |
DEC / 13 |